Advertisement

Pharmacy World and Science

, Volume 26, Issue 3, pp 129–132 | Cite as

Changing a profession, influencing community pharmacy

  • J.W. Foppe van Mil
  • Bente Frokjær
  • Dick F.J. Tromp
Article

Abstract

The authors set out to describe the possible impact of the continuing education activities of the Community Pharmacy Section (CPS) of the International Pharmaceutical Federation (FIP) on the profession in the period from 1980 to 2002 (approximately the last two decades of the 20th century) by reviewing and interpreting documents of the Community Pharmacy Section of the International Pharmaceutical Federation. The educational activities of the CPS have resulted in a high level of satisfaction among the participants. The CPS has also coordinated international practice research and the dissemination of the concept of pharmaceutical care. Additionally, the section's activities have informed the members of national pharmaceutical associations about new concepts, and stimulated projects on the added value of pharmacy. There are reasons to believe that the activities have created agents of change. It seems that the activities of the section have had some effect, although the exact impact remains difficult to measure because no structured evaluation method has been applied from the beginning of the continuing education activities.

Community pharmacy practice FIP Professional change 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    FIP Statement of Professional Standards: Code of Ethics for Pharmacists. Adopted 1997 in Vancouver. FIP, The Hague, The Netherlands. Retrieved from http://www.fip.org/pdf/codeeth.pdf on 2 June 2003.Google Scholar
  2. 2.
    McCombs JS, Nichol MB, Johnson KA, Hay JW, Ebin VJ, Lawrence GD et al. Is pharmacy's vision of the future too narrow? Am J Health Syst Pharm 1995; 52: 1208–14.Google Scholar
  3. 3.
    UN Universal Declaration of Human Rights. Adopted 1948. UN, New York. Retrieved from http://www.un.org/overview/rights.html on 14 March 2002.Google Scholar
  4. 4.
    World Medical Association Declaration of Helsinki, Adopted 2000. Retrieved from http://www.wma.net/e/policy/b3.htm on 2 June 2003.Google Scholar
  5. 5.
    Tully MP, Hassell K, Noyce PR. Advice-giving in community pharmacies in the UK. J Health Serv Res Policy 1997; 2: 38–50.Google Scholar
  6. 6.
    Graham J. What consumers want to know about their medicines. Aust Prescr 1995; 18: 10–11.Google Scholar
  7. 7.
    Nimmo CM, Holland RW. Transitions in pharmacy practice, part 4: can a leopard change its spots? Am J Health Syst Pharm 1999; 56: 2458–62.Google Scholar
  8. 8.
    Zellmer WA. Role of pharmacy organizations in transforming the profession: the case of pharmaceutical care. Am J Health Syst Pharm 2001; 58: 2041–9.Google Scholar
  9. 9.
    Rogers EM. Diffusion of innovations, 4th ed. New York: The Free Press, 1995.Google Scholar
  10. 10.
    Holland RW, Nimmo CM. Transitions, part 1: beyond pharmaceutical care. Am J Health Syst Pharm 1999; 56: 1758–64.Google Scholar
  11. 11.
    Nimmo CM, Holland RW. Transitions in pharmacy practice, part 2: who does what and why. Am J Health Syst Pharm 1999; 56: 1981–7.Google Scholar
  12. 12.
    Holland RW, Nimmo CM. Transitions in pharmacy practice, part 3: effecting change—the three ring circus. Am J Health Syst Pharm 1999; 56: 2235–41.Google Scholar
  13. 13.
    Nimmo CM, Holland RW. Transitions in pharmacy practice, part 5: walking the tightrope of change. Am J Health Syst Pharm. 2000; 57: 64–72.Google Scholar
  14. 14.
    Webb JW. Harvey A.K. Whitney lecture. The art of growing professionally. Am J Hosp Pharm 1986; 43: 1923–6.Google Scholar
  15. 15.
    Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 2001; 18: 63–7.Google Scholar
  16. 16.
    Herborg H, Søndergaard B, Frøkjaer B, Fonnesbaek L, Jorgensen T, Hepler CD et al. Improving drug therapy for patients with asthma part 1: patient outcomes. J Am Pharm Assoc (Wash) 2001; 41: 539–50.Google Scholar
  17. 17.
    Schulz M, Verheyen F, Mühlig S, Müller JM, Mühlbauer K, Knop-Schneikert E et al. Pharmaceutical Care Services for Asthma Patients: a controlled Intervention Study. J Clin Pharmacol 2001; 41: 668–76.Google Scholar
  18. 18.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43.Google Scholar
  19. 19.
    Miller MJ, Ortmeier BG. Factors influencing the delivery of pharmacy services. Am Pharm 1995 NS35(1): 39–45.Google Scholar
  20. 20.
    van Mil JWF, de Boer WO, Tromp ThFJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract 2001; 9: 163–7.Google Scholar
  21. 21.
    van Mil JWF, Mobach MP, Tromp ThFJ. The PharmValue project V7. FIP/QIPC, Kampen, The Netherlands, 2000. Retrieved from www.qipc.nl/pharmvalue on 1 January 2003.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • J.W. Foppe van Mil
    • 1
  • Bente Frokjær
    • 2
  • Dick F.J. Tromp
    • 3
  1. 1.Margrietlaan 1ZuidlarenThe Netherlands
  2. 2.PharmakonDanish College of Pharmacy PracticeHillerødDenmark
  3. 3.Institute for Pharmaceutical CareKampenThe Netherlands

Personalised recommendations